Tong Cui

Dr. Tong Cui


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2024 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
YLYaqin Li
Yaqin Li
JLJianping Lu
Jianping Lu
JSJingru Shi
Jingru Shi
LZLingjiao Zhang
Lingjiao Zhang
HMHaibo Mu
Haibo Mu
TCTong Cui
Tong Cui
The simultaneous administration of antibacterial treatment and acceleration of tissue regeneration are crucial for the effective healing of infected wounds. In this work, we developed a facile hydrogel (PCC hydrogel) through coordination and hydrogen interactions by polymerizing acrylamide monomers in the presence of carboxymethyl chitosan nanoparticles and copper ions. The prepared PCC hydrogel demonstrated effective bacterial capture from wound exudation and exhibited a potent bactericidal activity against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Furthermore, slow release of copper ions from the hydrogel facilitated wound healing by promoting cell migration, collagen deposition and angiogenesis. Additionally, the PCC hydrogel possessed excellent biocompatibility and hemostatic properties. The practical effectiveness of PCC hydrogel in addressing bacterial infections and facilitating wound healing was verified using a mouse model of MRSA-induced wound infections. Overall, this work presents a simple yet efficient multifunctional hydrogel platform that integrates antibacterial activity, promotion of wound healing, and hemostasis for managing bacteria-associated wounds.

25 August 2026 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
XZXiaoyan Zhu
Xiaoyan Zhu
TZTao Zhang
Tao Zhang
TGTing Gu
Ting Gu
HSHai Su
Hai Su
YRYanyan Ren
Yanyan Ren
TCTong Cui
Tong Cui
Citrus-derived flavonoids, particularly naringenin, hesperidin, and hesperetin, have emerged as promising bioactive compounds with potential therapeutic relevance in hepatocellular carcinoma (HCC). This review provides a focused synthesis of current preclinical evidence regarding their anticancer properties and underlying molecular mechanisms in experimental HCC models. These flavonoids exert broad anticancer effects, including inhibition of cell proliferation, induction of apoptosis, reduction of oxidative stress, and suppression of tumor progression and metastasis. These activities are mediated through modulation of key oncogenic signaling pathways, which are critically involved in hepatocarcinogenesis. In addition, citrus flavonoids influence mitochondrial function and cellular redox homeostasis, thereby contributing to programmed cell death and metabolic regulation. Preclinical studies further indicate that these compounds may enhance the efficacy of conventional chemotherapeutic agents, including cisplatin, doxorubicin, and sorafenib, while exhibiting reduced toxicity toward normal cells. Moreover, nanoformulation-based delivery systems have been shown to improve their bioavailability and therapeutic performance in experimental models. In vivo evidence supports their hepatoprotective effects, with reductions in tumor burden and attenuation of inflammation and fibrosis. Collectively, citrus flavonoids represent promising adjunctive candidates for HCC therapy; however, clinical validation remains limited, and further translational studies are required to confirm their therapeutic applicability in humans.